However, when you look closer, many of the claims made are unverified , unrealistic , or flat-out misleading
Didnt expect it to be this easy
Teenagers (ages 13 to 18) received less than 0.5% of prescriptions written for the top four GLP-1 drugs to patients without diabetes between 2018 and May 2023
the prescription routes to a retail pharmacy for brand products or a 503A compounding pharmacy for compounded semaglutide or tirzepatide
Patients should not take these medications solely for brain protection without consulting a healthcare professional
A Shot Every Two Weeks Instead of Weekly: New GLP-1 Drug Shows Strong Trial Results A new GLP-1 receptor agonist that requires only one injection every two weeks rather than the weekly shots required by Ozempic, Wegovy, and Mounjaro has shown strong results in a Phase 2b clinical trial, with meaningful reductions in blood sugar levels and body weight in adults with type 2 diabetes